Global Virtual Eating Disorder Treatment Market By Type (Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder (BED), Other Types), By End-User (Hospitals, Clinics, Other End Users), By Patient, By Treatment, By Route of Administration, By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021–2031

Introduction

Eating disorders are serious conditions related to compulsive eating behaviors that negatively impact an individual’s health, emotional well-being, and the ability to function appropriately in various important areas of their life. The most common eating disorders are anorexia nervosa, bulimia nervosa, and binge-eating disorder. Other eating disorders include rumination disorder and avoidant/restrictive food intake disorder.

Most eating disorders are centered around an individual irrationally focusing on weight, body shape, and food, leading to the development of these aforementioned dangerous eating behaviors. These disorders can significantly impact the body’s ability to receive adequate nutrition. Eating disorders can harm the heart, the digestive system, bones, teeth & mouth, as well as act as a gateway to other diseases.

Eating disorders commonly gain a foothold during the teen and young adult years of an individual, however, they have been known to develop at other ages as well. With appropriate treatment, an individual is able to re-inforce healthier eating habits, and in certain cases, they are able to reverse serious complications caused by their given eating disorder/s. Symptoms may vary, depending on the type of eating disorder/s.

Eating disorders can be diagnosed by medical physicians or mental health professionals, including psychiatrists and psychologists. Often, a pediatrician or primary care doctor will diagnose an eating disorder after identifying symptoms during a given regular check-up, or after a parent or family member expresses concern over their loved one’s behavior.

Although there is no one laboratory test to screen for eating disorders, a doctor can employ a variety of physical and psychological evaluations as well as lab tests to determine an individual’s diagnosis, including a physical exam, during which your healthcare provider will establish your height, weight, and other vital signs. Lab tests, including a complete blood count, liver, kidney, and thyroid function tests, urinalysis, X-ray, and an electrocardiogram. Psychological evaluations include personal questions about an individual’s eating behaviors, potential binging, purging, exercise habits, and BMI.

There are even multiple questionnaires and assessment tools that are used to assess an individual’s specific symptoms, including Eating Disorder Inventory, SCOFF Questionnaire, Eating Attitudes Test, and an Eating Disorder Examination Questionnaire (EDE-Q).

Detailed Segmentation

Global Virtual Eating Disorder Treatment Market Segmentation Based on Type, Patient, Treatment, End-User, Route of Administration, and Regions/Countries

By Type

• Anorexia Nervosa
• Bulimia Nervosa
• Binge Eating Disorder (BED)
• Other Types

By Patient

• Inpatients
• Outpatients

By Treatment

• Medications
• Therapy
• Other Treatments

By End-User

• Hospitals
• Clinics
• Other End Users

By Route of Administration

• Oral
• Parenteral
• Other Route of Administrations

By Regions/Countries

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Mental health disorders, increasing biological factors such as changes in neurochemistry and increased social, emotional, or psychological stress, which decreases self-esteem. Perfectionism is another element that is slated to boost the projected revenue growth of the virtual eating disorder treatment market as well. However, a surge in the prevalence of eating disorders, and cases of sleep deprivation, particularly in adults, more so among the adult female population. However, no approved forms of treatment concerning eating disorders, and the lack of adequate awareness levels among patients, are factors that may hamper the further augmentation of the virtual eating disorder treatment market.

The COVID-19 pandemic has had a profoundly negative impact on individuals suffering from various eating disorders, thereby potentially inversely impacting market growth prospects for this global industry.

Key players:

• The Renfrew Center
• Alsana West LLC
• Bausch & Lomb Incorporated
• Apotex Inc.
• Somerset Therapeutics LLC
• Mylan N.V
• Teva Pharmaceuticals Industries Ltd.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Amneal Pharmaceutical Inc.
• Eli Lilly and Company
• AbbVie Inc.
• GlaxoSmithKline Plc

Recent Developments

Year 2021

• In March, AbbVie entered into an agreement to acquire PINK1 Compound from Mitokinin.
• Acquisitions/Mergers/Takeovers: In February, AbbVie announced a 16.7% acquisition stake of Evolus.
• Pfizer entered into a partnership with Premier’s ProvideGx program to supply five forms of essential medication to healthcare providers.

Year 2020

• In January, Pfizer signed a research agreement with InSilico Medicine to utilize Insilico’s platform as a means of exploring data necessary for potential therapeutic targets in a variety of diseases.

Year 2019

• In January, GSK, Takeda, and Teva collaborated to announce the launch of the Responsible Health Initiative to improve visibility, efficiency, and the sustainability impacts of the global healthcare supply chain.

For the Virtual Eating Disorder Treatment Market research study, the following years have been considered to estimate the market size: